Marlène Thomas

1.8k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Marlène Thomas is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Marlène Thomas has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Marlène Thomas's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Teacher Education and Leadership Studies (4 papers). Marlène Thomas is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Teacher Education and Leadership Studies (4 papers). Marlène Thomas collaborates with scholars based in Switzerland, Germany and France. Marlène Thomas's co-authors include Oleg Gladkov, Julie Hill, Feng-yi Feng, Michaela Lehle, Jian Xu, Keun-Wook Lee, Josef Rüschoff, Shunchang Jiao, Vivian Ng and Timothy Price and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal Of Pathology.

In The Last Decade

Marlène Thomas

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

2014 426 citations Eric Van Cutsem, Yung‐Jue Bang et al. Gastric Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marlène Thomas Switzerland	14	627	402	278	233	203	30	1.1k
Kristen J. Pierce United States	14	350 0.6×	209 0.5×	41 0.1×	524 2.2×	105 0.5×	33	1.0k
Wolfram Jung Germany	17	821 1.3×	182 0.5×	401 1.4×	316 1.4×	87 0.4×	41	1.7k
Yinghong Yang China	13	227 0.4×	120 0.3×	36 0.1×	153 0.7×	99 0.5×	44	557
S-A. Im South Korea	18	799 1.3×	454 1.1×	163 0.6×	324 1.4×	242 1.2×	85	1.1k
N. Al-Sakaff Switzerland	11	901 1.4×	357 0.9×	338 1.2×	163 0.7×	320 1.6×	27	1.2k
Shivan Sivakumar United Kingdom	15	643 1.0×	355 0.9×	126 0.5×	317 1.4×	275 1.4×	40	1.0k
Dorothy W. Pan United States	9	894 1.4×	437 1.1×	119 0.4×	226 1.0×	119 0.6×	27	1.3k
Alan Nicholas United States	13	697 1.1×	430 1.1×	46 0.2×	135 0.6×	191 0.9×	23	1.5k
Shin‐ichi Tsuchiya Japan	19	304 0.5×	231 0.6×	123 0.4×	269 1.2×	287 1.4×	79	1.0k
Dara S. Ross United States	18	725 1.2×	388 1.0×	361 1.3×	272 1.2×	381 1.9×	58	1.2k

Countries citing papers authored by Marlène Thomas

Since Specialization

Citations

This map shows the geographic impact of Marlène Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlène Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlène Thomas more than expected).

Fields of papers citing papers by Marlène Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlène Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlène Thomas. The network helps show where Marlène Thomas may publish in the future.

Co-authorship network of co-authors of Marlène Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Marlène Thomas. A scholar is included among the top collaborators of Marlène Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlène Thomas. Marlène Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tourneau, Christophe Le, Fabrice André, Åslaug Helland, et al.. (2023). Modified study designs to expand treatment options in personalised oncology: a multistakeholder view. European Journal of Cancer. 194. 113278–113278. 3 indexed citations

Paz‐Ares, Luis, Ádám Gondos, Marlène Thomas, et al.. (2022). Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study. Lung Cancer. 167. 41–48. 27 indexed citations

Pauli, Chantal, Tilmann Bochtler, Linda Mileshkin, et al.. (2021). A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience. The Oncologist. 26(5). e769–e779. 38 indexed citations

Ross, Jeffrey S., Ethan S. Sokol, Holger Moch, et al.. (2020). Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design. The Oncologist. 26(3). e394–e402. 44 indexed citations

Bensch, Frederike, Laetitia E. Lamberts, Annelies Jorritsma‐Smit, et al.. (2017). 89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors. Clinical Cancer Research. 23(20). 6128–6137. 57 indexed citations

Thomas, Marlène, et al.. (2017). Preparedness of Graduate-Teachers from the University of Trinidad and Tobago for the Real Classroom. International Journal of Humanities Social Sciences and Education. 4(10). 1 indexed citations

Meneses‐Lorente, Georgina, Christine McIntyre, Joy Hsu, et al.. (2017). Accelerating drug development by efficiently using emerging PK/PD data from an adaptable entry-into-human trial: example of lumretuzumab. Cancer Chemotherapy and Pharmacology. 79(6). 1239–1247. 3 indexed citations

Thomas, Marlène, et al.. (2016). Constructivism- Linking Theory with Practice among Pre-Service Teachers at the University of Trinidad and Tobago. International Journal of Learning Teaching and Educational Research. 15(7). 2 indexed citations

Muckenhuber, Alexander, Marlène Thomas, Gabriele Hölzlwimmer, et al.. (2016). Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies. Pancreas. 45(8). 1167–1174. 3 indexed citations

10.

Zając, Magdalena, Thomas Friess, Natascha Rieder, et al.. (2015). Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA). Molecular & Cellular Proteomics. 14(10). 2775–2785. 7 indexed citations

11.

Meneses‐Lorente, Georgina, Thomas Friess, Gabriele Hölzlwimmer, et al.. (2015). Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody. Cancer Chemotherapy and Pharmacology. 75(4). 837–850. 13 indexed citations

12.

Schmid, Volker, Dieter Heindl, Sebastian Dziadek, et al.. (2014). Development of Bispecific Molecules for the In Situ Detection of Protein-Protein Interactions and Protein Phosphorylation. Chemistry & Biology. 21(3). 357–368. 7 indexed citations

13.

Scheltinga, Anton G.T. Terwisscha van, Marjolijn N. Lub–de Hooge, K. Abiraj, et al.. (2014). ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody⁸⁹Zr-RG7116. mAbs. 6(4). 1051–1058. 46 indexed citations

14.

Cutsem, Eric Van, Yung‐Jue Bang, Feng-yi Feng, et al.. (2014). HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer. 18(3). 476–484. 426 indexed citations breakdown →

15.

Prat, Aleix, Giampaolo Bianchini, Marlène Thomas, et al.. (2014). Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study. Clinical Cancer Research. 20(2). 511–521. 158 indexed citations

16.

Thomas, Marlène, et al.. (2013). An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samples. PubMed. 3(1). 10–10. 13 indexed citations

17.

Mouquet, Hugo, Kossara Drenovska, P. Joly, et al.. (2008). Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay. Clinical Immunology. 129(2). 304–312. 15 indexed citations

18.

Thomas, Marlène, et al.. (2007). Use of and satisfaction with Community Aged Care Packages in the eastern suburbs of Sydney. Australasian Journal on Ageing. 26(1). 8–14. 12 indexed citations

19.

Mouquet, Hugo, Laurent Drouot, Christophe Arnoult, et al.. (2006). Proteomic analysis of the autoantibody response following immunization with a single autoantigen. PROTEOMICS. 6(17). 4829–4837. 7 indexed citations

20.

Goëb, Vincent, Philippe Dieudé, Olivier Vittecoq, et al.. (2005). Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis. Arthritis Research & Therapy. 7(5). R1056–62. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact